Clinical Scorecard: The Role of Insulin Resistance in Predicting Long-Term Cardiovascular Event Risk in Atrial Fibrillation Patients After Radiofrequency Catheter Ablation

At a Glance

Key Highlights

• METS-IR and TyG-BMI are significantly associated with elevated MACE risk post-ablation.
• MACEs occurred in 26.25% of patients over a median follow-up of 36 months.
• METS-IR showed a linear dose-response relationship with MACEs.
• METS-IR improved the C-statistic from 0.702 to 0.717 when added to baseline clinical models.
• The study emphasizes the need for improved risk stratification in AF patients post-ablation.

Guideline-Based Recommendations

Diagnosis

• Evaluate insulin resistance indices in atrial fibrillation patients.

Management

• Consider METS-IR for post-ablation risk assessment.

Monitoring & Follow-up

• Monitor for major adverse cardiovascular events in AF patients after RFCA.

Risks

• Patients with elevated insulin resistance indices are at higher risk for MACEs.

Patient & Prescribing Data

922 non-valvular AF patients undergoing RFCA.

Insulin resistance may be a modifiable risk factor in AF management.

Clinical Best Practices

• Incorporate insulin resistance assessment in routine evaluations of AF patients.
• Utilize METS-IR for enhanced risk stratification post-ablation.

Related Resources & Content

• Luo et al., 2024
• Qin et al., 2025